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Abstract
Background: Gestational diabetes mellitus (GDM) is increasing and is a risk for type 2 diabetes. Evidence supporting
screening comes mostly from high-income countries. We aimed to determine prevalence and outcomes in urban Viet Nam.
We compared the proposed International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criterion,
requiring one positive value on the 75-g glucose tolerance test, to the 2010 American Diabetes Association (ADA) criterion,
requiring two positive values.
Methods and Findings: We conducted a prospective cohort study in Ho Chi Minh City, Viet Nam. Study participants were
2,772 women undergoing routine prenatal care who underwent a 75-g glucose tolerance test and interview around 28
(range 24–32) wk. GDM diagnosed by the ADA criterion was treated by local protocol. Women with GDM by the IADPSG
criterion but not the ADA criterion were termed ‘‘borderline’’ and received standard care. 2,702 women (97.5% of cohort)
were followed until discharge after delivery. GDM was diagnosed in 164 participants (6.1%) by the ADA criterion, 550
(20.3%) by the IADPSG criterion. Mean body mass index was 20.45 kg/m2 in women with out GDM, 21.10 in women with
borderline GDM, and 21.81 in women with GDM, p,0.001. Women with GDM and borderline GDM were more likely to
deliver preterm, with adjusted odds ratios (aORs) of 1.49 (95% CI 1.16–1.91) and 1.52 (1.03–2.24), respectively. They were
more likely to have clinical neonatal hypoglycaemia, aORs of 4.94 (3.41–7.14) and 3.34 (1.41–7.89), respectively. For large for
gestational age, the aORs were 1.16 (0.93–1.45) and 1.31 (0.96–1.79), respectively. There was no significant difference in
large for gestational age, death, severe birth trauma, or maternal morbidity between the groups. Women with GDM
underwent more labour inductions, aOR 1.51 (1.08–2.11).
Conclusions: Choice of criterion greatly affects GDM prevalence in Viet Nam. Women with GDM by the IADPSG criterion
were at risk of preterm delivery and neonatal hypoglycaemia, although this criterion resulted in 20% of pregnant women
being positive for GDM. The ability to cope with such a large number of cases and prevent associated adverse outcomes
needs to be demonstrated before recommending widespread screening.
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Introduction
Diabetes is rising globally. It is predicted that 438 million people
will be living with diabetes by 2020, and 50% of these will reside in
Asia [1]. Countries undergoing social, economic, and nutritional
transition are experiencing the greatest increase in prevalence,
with commensurate impact on health service delivery. Gestational
diabetes mellitus (GDM) is associated with a 7-fold increased risk
of developing type 2 diabetes in the future [2], thus identification
could have importance for preventative health strategies. The
adverse maternal and foetal effects of GDM are well known [3].
The Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO)
cohort study involving over 23,000 women demonstrated strong
evidence of a continuous rather than threshold relationship with
rising glycaemia [4]. Such evidence, in addition to the findings of
two randomised trials supporting treatment for mild hyperglycae-
mia [3,5], has prompted the International Association of the
Diabetes and Pregnancy Study Groups (IADPSG) to revise
screening and diagnostic criteria for GDM. It has been proposed
that all pregnant women undergo a 75-g oral glucose tolerance test
(OGTT) around 28 wk gestation, with the threshold for diagnosis
of GDM based on increased perinatal risk rather than future risk
of developing diabetes or non-pregnancy values [6]. There is
concern that these new guidelines will increase the number of
women diagnosed with GDM, with a possible increase in
iatrogenic intervention, with more pregnancies labelled ‘‘high
risk’’ [7]. It is pertinent that evidence for the effectiveness of
screening and treatment of GDM comes from high-income
settings [8,9], and direct transfer into other contexts may not
replicate the same benefits.
Viet Nam is a low/middle-income Southeast Asian country with
a population of approximately 87 million. In 2009, gross domestic
product per capita was estimated at US$1,191 [10]. Type 2 diabetes
is rising. In 2010 a population-based study found a prevalence of
11% in adult women residing in Ho Chi Minh City [11]. Few data
are available on the prevalence of GDM in Viet Nam and associated
perinatal outcomes, although rates in expatriate Vietnamese women
are known to be high [12]. In southern Viet Nam the rate of
institutional delivery and antenatal care is high [13], yet screening
for GDM is not uniform and, if it occurs, is risk factor based. State-
run maternity hospitals are frequently overcrowded and lack
support from nutritionists and diabetes educators.
The aim of this study was to determine prevalence of GDM and
follow women through pregnancy to assess the perinatal outcomes
associated with gestational diabetes in urban Viet Nam. Given
current international controversy over the optimal diagnostic
criteria to use in order to prevent complications from GDM, we
compared outcomes in women and their babies diagnosed with
GDM by the American Diabetes Association (ADA) 2010 criterion
[14] to outcomes for the additional women and babies that would
be diagnosed by the less stringent IADPSG criterion [6].
Methods
Ethics Statement
Ethical approval was obtained from the University of Sydney
(Human Research Ethics Committee approval number 13200)
and the Hung Vuong Hospital Ethics Approval Board (approval
number 725/QÐ-BVHV) prior to commencement of the study.
All study participants were given written and oral information
about the study and provided written informed consent to
participate and have birth outcomes reviewed after delivery.
There was no financial or other incentive to join the study,
however, as Viet Nam has a user-pays health system; the cost of
the OGTT was covered by the study protocol.
Study Setting and Population
We carried out a prospective cohort study assessing the
perinatal outcomes associated with GDM in Hung Vuong
Hospital, Ho Chi Minh City. This hospital serves as a local and
referral hospital for women in the city and surrounding provinces
and conducted around 35,000 deliveries in 2010. Around a
quarter of the women who deliver in the hospital are local women
receiving routine antenatal care through the outpatient depart-
ments, and these women represented the target population for this
study. Women referred from other hospitals or private clinics for
management of antenatal complications or delivery were exclud-
ed, as it was felt they would not reflect population norms.
Womenwere approached in the antenatal outpatient department by
one of three trained research midwives and screened for eligibility.
Women were eligible if they were receiving antenatal care through the
hospital outpatient departments, were aged over 18 y, had confirmed
gestation between 24 and 32 wk (by early ultrasound or certain last
menstrual period date), had a singleton pregnancy, planned to deliver
in the hospital, and were not known to have diabetes.
Participants were recruited from 1 December 2010 to 31 March
2011, and all women had delivered by 21 August 2011. All study
participants underwent a 75-g, 2-h OGTT between 24 and 32 wk
gestation, with testing as close to 28 wk as possible. Women were
given instructions to fast from midnight and present in the
morning for testing. Blood samples were collected fasting, 1 h, and
2 h after ingestion of 75 g of anhydrous glucose dissolved in
200 ml of water.
We aimed to follow through all women screened around 28 wk
of pregnancy until discharge from hospital following delivery
(usually within 5 d of birth). Women with GDM were approached
to undergo a short interview post-delivery to determine the
method of monitoring of glycaemia and management of GDM.
Data Collection
To assess sociodemographic characteristics and medical risk
factors for GDM, women completed a structured, 10-min
interview at the time of oral glucose tolerance testing conducted
by one of three trained research midwives. Weight, height, and
blood pressure were determined from the first antenatal visit
record and measured again at the time of the OGTT. This
interview solicited information about known and possible risk
factors for GDM as well as basic pregnancy, health, social, and
demographic information. The interview was trialled on around
100 women for acceptability and applicability prior to commence-
ment of the main study.
To assess GDM status, blood samples were collected from the ante
cubital fossa and processed within 1 h of collection using the glucose
hexokinase enzymatic method (Roche/cobase c system c501).
Calibration was performed with each new batch of reagent or every
2 d, whichever was sooner, as per the manufacturer’s instructions. If
values were obtained outside the reference range, recalibration was
performed and the samples retested to confirm the result.
To assess perinatal outcomes, all medical records of mothers
and their babies were reviewed after hospital discharge, and data
were extracted by research midwives using a standardised form.
Phone calls were made to women lost to follow-up to obtain basic
birth outcome information.
The ADA criterion for GDM [14] requires two or more of the
following glucose values: fasting glucose $95 mg/dl (5.3 mmol/l),
1-h glucose $180 (10.0), and/or 2-h glucose $155 (8.6). The
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IADPSG criterion [6] requires only one of the following glucose
values: fasting glucose $92 mg/dl (5.1 mmol/l), 1-h glucose $180
(10.0), or 2-h glucose$153 (8.5). Three strata were defined: women
with GDM according to both the ADA criterion and the IADPSG
criterion (considered as having GDM), women with GDM by the
IADPSG criterion alone (considered ‘‘borderline’’), and women
without GDM by either criterion (considered ‘‘normal’’).
Only women with GDM according to the ADA criterion were
notified of their diagnosis and referred for dietary advice and
glucose monitoring. All other women received standard antenatal
care. The hospital had a loan system for home blood glucose
monitors, although women pay a deposit for disposables and many
prefer to come to the hospital weekly to check a fasting blood
glucose level. Whilst there was no formally trained nutritionist or
diabetes educator at the hospital, all women with GDM were
given advice about nutrition from a doctor. Women with
persistently raised fasting glucose (.7.0 mmol/l [126 mg/dl]) or
1-h post-prandial glucose (.11.1 mmol/l [200 mg/dl]) were
commenced on insulin. At the time of the study, metformin was
not licensed for use in pregnancy in Viet Nam and therefore was
not used by any study participants.
The primary outcome for the study was increased neonatal
growth, defined as large for gestational age (LGA),i.e., birth weight
greater than the 90th population percentile for gestation and foetal
gender. Birth weight was determined immediately after birth using
digital scales accurate to the nearest 10 g (Tanita BD-590), and
local birth-weight-for-gestation charts used. Other neonatal
outcomes were as follows: preterm birth (,37 wk), death after
study recruitment, small for gestational age (SGA), birth weight
less than or equal to the tenth population percentile, intensive
neonatal care, jaundice requiring phototherapy (initiated at
bilirubin levels of .257 mmol/l at 25–48 h of age, .308 mmol/l
at 49–72 h of age, or .342 mmol/l after 72 h of age), and
symptomatic clinical neonatal hypoglycaemia, defined if there was
a notion of hypoglycaemia in the medical record and either
treatment with a glucose infusion or a recording of blood glucose
level ,2.6 mmol/l (46 mg/dl) within the first 48 h of life.
Maternal outcomes were induction of labour, primary caesar-
ean section, postpartum haemorrhage (using the World Health
Organization definition of .500 ml of blood loss in the first 24 h
after birth [15]), severe perineal trauma (defined as laceration
involving the anal sphincter), and preeclampsia (defined as blood
pressure .140/90 mm Hg on at least two occasions and
proteinuria .300 g in 24 h [16]).
Sample Size
Sample size was based on estimation of LGA in the borderline
group being 1.75 times higher that in the non-GDM group, as per
the findings of the HAPO cohort study [4], upon which the
IADPSG criterion was based [6]. The prevalence of GDM and
LGA in this population had not been previously studied. Given
prevalence in similar Asian populations, it was estimated that 7%
of women would have GDM by the ADA criterion, and a further
7% would be borderline. If LGA prevalence were 10% in the
normal group and 17.5% in the borderline group, for a power of
80% and two-sided significance of 0.05, approximately 2,295
women would be required in the cohort (using Fleiss with
continuity correction). Allowing for 10% loss to follow-up, the
study aimed to recruit at least 2,525 women.
Statistical Analysis
All data were entered, verified, and hosted on a password-
protected database. Any discrepancies and outlying results were
reviewed. Identifying data for mothers and babies were removed.
Data were analysed using STATA version 10.0 (StataCorp). All
available data were used for analysis.
Categorical analysis compared mothers and babies in the three
GDM strata (GDM, borderline, and normal). Maternal glycaemia
was also analysed as a continuous variable, to determine the ability
of the fasting, 1-h, and 2-h tests to predict adverse outcomes. This
was felt to be an appropriate method for analysis, as categorisation
of continuous variables risks losing information [17]. Adjusted
odds ratios (aORs) for each increase in one standard deviation
(SD) of glycaemia were calculated.
ANOVA univariate analysis was performed using a two-sample
t-test with equal variances for continuous variables and a Pearson
x2 test to compare categorical variables. Multiple regression was
performed with previously published confounding variables
(purposeful selection). Unadjusted and adjusted odds ratios were
calculated, with adjustment for age, body mass index (BMI) at the
first antenatal visit, height at OGTT, partner’s indoor smoking
habit, family history of diabetes or hypertension, gestational age at
OGTT, foetal sex, parity (not included in model for primary
caesarean section), hospitalisation prior to delivery (not included in
model for preeclampsia, primary caesarean section), and mean
arterial blood pressure at the first antenatal visit (not included in
model for preeclampsia).
Sensitivity analysis was conducted for women lost to follow-up.
Results
Sample Characteristics and Cohort Follow-Up
The numbers of women approached and recruited into the
study, as well as those lost to follow-up, are shown in Figure 1.
From 1 December 2010 to 31 March 2011, 4,802 women
presenting for routine antenatal care at Hung Vuong Hospital
were screened for eligibility, with 2,952 women found eligible. The
most common reason for ineligibility was planning to deliver
elsewhere, with many city workers planning to return to their
home province for delivery. Of eligible women, 2,824 consented to
participate in the study, with 2,772 completing the OGTT (94% of
eligible women). Complete birth and outcome data were available
for 2,702 women and babies (97.5% of cohort). There were 70
women lost to follow-up, with no significant differences in basic
demographic characteristics between them and the remainder of
the cohort.
Maternal baseline characteristics are shown in Table 1. The
mean gestation for the first antenatal visit was 12 wk (SD 6.6 wk)
and mean gestation at OGTT was 28 wk (SD 1.7 wk). Women in
the borderline GDM group were older, were of higher parity, had
higher BMI, and were more likely to have a family history of
diabetes women in the normal group. In addition to these risk
factors, women with GDM were also more likely to have had GDM
in a previous pregnancy, a prior caesarean section, a prior stillbirth
or baby.4,000 g at birth, and/or a family history of hypertension.
No women in the study stated that they smoked in pregnancy.
Reported rates of pre-pregnancy hypertension were low in all
groups (four women in the normal group, two women in the
borderline group, and two in the GDM group), with no significant
difference between groups.
Maternal Glycaemia and Prevalence of Gestational
Diabetes
Maternal glycaemia and prevalence of GDM are shown in
Table 2. The median (range) of fasting, 1-h, and 2-h glucose levels
was 4.4 (3.1–8.2), 7.9 (3.7–14.8), and 6.9 (3.3–15.2) mmol/l,
respectively. There were 164 women (6.07%) with GDM by the
ADA criterion and 550 women (20.36%) with GDM by the
Gestational Diabetes Mellitus in Viet Nam
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IADPSG criterion. Thus, 386 women were classified as borderline
for the study purpose. There were 23 women (0.9%) with overt
diabetes based on fasting glucose .7.0 mmol/l (126 mg/dl) or 2-h
glucose .11.1 mmol/l (200 mg/dl). These women were included
in the GDM group for analysis.
Management of Gestational Diabetes
Of the 164 women diagnosed with GDM by the ADA criterion,
11 were commenced on insulin by the time of delivery (6.7%).
Data were available on the method of glucose monitoring for 143
women (87% of the GDM group). 107 women performed home
blood glucose monitoring. The frequency of self home monitoring
varied, with 78 women testing glucose levels up to twice per week
and three women testing more than four times per week. There
were 36 women who underwent weekly or second weekly testing at
the hospital or local clinic.
Survival
There were no maternal deaths, 2,696 live births, six late-
trimester stillbirths, and six neonatal deaths prior to hospital
discharge in the cohort (Table 3). Three babies were born with
major congenital malformations. There was no significant
difference in perinatal mortality between the three groups;
however, the study was not powered to demonstrate a difference
in this outcome.
Neonatal Outcomes
Neonatal outcomes comparing women in the normal (referent)
group to women in the borderline and GDM groups are shown in
Table 3. Babies born to women in the GDM group were more
likely to be born preterm (14.02% in the GDM group compared to
6.55% in the normal group, p=0.002, aOR 1.49, 95% CI 1.16–
1.91). Importantly, this relationship was also demonstrated in the
Figure 1. Flow chart of participants in cohort study.
doi:10.1371/journal.pmed.1001272.g001
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borderline group, where 9.59% of babies were born preterm,
which was also significantly increased from the rate seen in the
normal group (p=0.03, aOR 1.52, 95% CI 1.03–2.24). There was
also a higher chance of developing clinical neonatal hypoglycae-
mia in the GDM group (14.02% in the GDM group compared to
0.70% in the normal group, p,0.001, aOR 4.94, 95% CI 3.41–
7.14). Increased risk was also demonstrated in the borderline
group, with 2.33% of babies requiring treatment for hypoglycae-
mia compared to 0.70% in the normal group (p=0.01, aOR 3.34,
95% CI 1.41–7.89). The proportion of babies that were LGA was
greater in the GDM (18.90%) and borderline (16.06%) groups
compared to in the normal group (11.76%); however, this was not
statistically significant once confounders, particularly BMI and
age, were adjusted for: aOR 1.16 (95% CI 0.93–1.45) in the GDM
group and aOR 1.31 (95% CI 0.96–1.79) in the borderline group.
There was no significant difference in death, birth trauma,
neonatal jaundice requiring treatment, or neonatal intensive care
between the borderline or GDM group and the normal group.
Maternal Outcomes
Maternal outcomes comparing women in the normal (referent)
group to those in the borderline and GDM groups are shown in
Table 4. Women with GDM were more likely to require antenatal
hospitalisation (10.98% in women with GDM versus 4.88% in
women without GDM, p,0.001, unadjusted odds ratio 2.25, 95%
CI 1.40–3.61). Women in the GDM group were more likely to
undergo primary caesarean section than women in the normal
group (40.85% versus 33.46%, respectively); however, the increase





(Percent) p-Value GDM, n=164 (Percent) p-Value
Mean age, in years (SD) 27.85 (4.73) 29.37 (4.89) ,0.001 31.21 (4.16) ,0.001
Mean BMIb (SD) 20.45 (2.63) 21.10 (2.99) ,0.001 21.81 (3.12) ,0.001
Mean arterial pressure (SD)c 77.65 (6.33) 78.45 (6.86) 0.02 78.46 (6.58) 0.12
Gestation at OGTT, in weeks (SD) 28.72 (1.75) 28.51 (1.69) 0.03 28.43 (1.79) 0.04
Gestation at first antenatal visit, in
weeks (SD)
12.00 (6.53) 12.42 (6.69) 0.24 12.26 (7.01) 0.63
Ethnicity Vietnamese 2,046 (95.07) 370 (95.85) 0.51 158 (96.34) 0.47
Educationd 0.85 0.54
Primary 162 (7.53) 31 (8.03) 14 (8.84)
Secondary 1,392 (64.68) 244 (63.21) 99 (60.37)
Tertiary 598 (27.79) 111 (28.76) 51 (31.10)
Parity = 0 1,412 (65.61) 225 (58.29) 0.006 76 (43.34) 0.002
Prior caesarean section 169 (7.85) 34 (8.81) 0.52 28 (17.07) ,0.001
Previous GDM 6 (0.28) 1 (0.26) 0.95 3 (1.83) 0.002
Previous stillbirth 64 (2.97) 9 (2.33) 0.49 12 (7.32) 0.003
Previous baby .4,000 g 20 (0.93) 5 (1.30) 0.50 5 (3.05) 0.011
Family history of diabetese 125 (5.81) 37 (9.59) 0.005 24 (14.63) ,0.001
Family history of hypertensione 372 (17.29) 70 (18.13) 0.69 48 (29.27) ,0.001
aIADPSG criterion for GDM positive, but ADA criterion negative.
bBMI (kg/m2) at first antenatal visit.
cMean arterial pressure at first antenatal visit (mm Hg).
dEducation level: primary, up to 5 y schooling; secondary, 6–12 y schooling; tertiary, .12 y schooling.
eFamily history in first degree relatives.
doi:10.1371/journal.pmed.1001272.t001
Table 2. Maternal glycaemia and prevalence of gestational diabetes.
Variable Result (Median, in mmol/l) or n Range (in mmol/l) or Percent
Fasting glycaemia 4.4 3.1–8.2
1-h glycaemia 7.9 3.7–14.8
2-h glycaemia 6.9 3.3–15.2
Normal (no GDM by either criterion) 2,152 79.64
GDM positive by IADPSG criterion 550 20.36
GDM positive by ADA criterion 164 6.07
Borderline groupa 386 14.29
aBorderline group is women positive for GDM using the IADPSG criterion, but negative on the ADA criterion.
doi:10.1371/journal.pmed.1001272.t002
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was no longer significant after adjustment for confounders (aOR
1.13, 95% CI 0.94–1.37). Women in the borderline group had a
slightly lower chance of primary caesarean section (31.35%,
compared to 33.46% in the normal group), which also was not
significant after adjustment (aOR 0.81, 95% CI 0.63–1.05).
Women with GDM had an increased risk of induction of labour
compared to women in the normal group; however, there was no
significant difference for the borderline group compared to the
normal group. The rate of preeclampsia overall was 1.70%, with
only one case recorded in the GDM group and 39 in the
borderline group, which was not significantly different to the
normal women.
The results of the fasting, 1-h, and 2-h OGTT results were
analysed as continuous variables for the major study outcomes.
The odds ratio was calculated for each increase in one SD of
glycaemia and is shown in Table 5. Significant relationships were
demonstrated, as glycaemia across all three tests increased with the
outcomes of LGA birth weight, neonatal hypoglycaemia, and
preterm birth (,37 wk gestation). There was a significant decrease
in the risk of SGA birth weight with rising 1-h and 2-h glycaemia,
although this was not demonstrated with increasing fasting
glycaemia. Labour induction also significantly increased with the
1-h and 2-h glycaemia results; however, again, this was not
demonstrated for increases in fasting glycaemia. There was no
statistically significant relationship between glycaemia and chance
of primary caesarean section.
Discussion
This study has demonstrated that there was an increase in
neonatal morbidity amongst the extra cases of GDM diagnosed
using the IADPSG criterion (the borderline group in this study).
Major adverse findings demonstrated in the borderline group were
an increase in the risk of preterm birth (,37 wk, aOR 1.52, 95%
CI 1.03–2.24) and an increase in neonatal hypoglycaemia (aOR
3.34, 95% CI 1.41–7.89). These conditions are both potentially
very serious in newborns, particularly in low-resource settings. We
did not demonstrate any significant difference in maternal
outcomes between the borderline and normal groups. The only
significant maternal outcome difference between the GDM group
and the normal group was an increase in the rate of induction of
labour (aOR 1.51, 95% CI 1.08–2.11), which was frequently
performed in women with GDM. We were not able to
demonstrate an increase in the chance of primary caesarean





(Percent) aORa (95% CI)
GDM, n=164
(Percent) aORa (95% CI)
Gestation at birth (weeks)b 38.85 (1.48) 38.64 (1.67) 0.20 (0.04–0.37) 38.31 (1.70) 0.53 (0.29–0.77)
Preterm delivery (,37 wk) 141 (6.55) 37 (9.59) 1.52 (1.03–2.24) 23 (14.02) 1.49 (1.16–1.91)
LGAc 253 (11.76) 62 (16.06) 1.31 (0.96–1.79) 31 (18.90) 1.16 (0.93–1.45)
SGAd 173 (8.04) 27 (6.99) 0.89 (0.58–1.37) 10 (6.10) 0.94 (0.67–1.32)
Clinical neonatal hypoglycaemia 15 (0.70) 9 (2.33) 3.34 (1.41–7.89) 23 (14.02) 4.94 (3.41–7.14)
Jaundice requiring phototherapy 65 (3.02) 16 (4.15) 1.39 (0.79–2.45) 7 (4.27) 1.16 (0.76–1.75)
Intensive neonatal caree 86 (4.0) 17 (4.40) 1.12 (0.65–1.91) 9 (5.49) 1.20 (0.83–1.73)
Perinatal death 9 (0.4) 3 (0.8) 1.68 (0.44–6.40) 0 (0) NA
aAdjusted for age, BMI at OGTT, height at OGTT, indoor partner’s smoking status, family history of diabetes, family history of hypertension, gestational age at OGTT,
baby’s sex, parity, hospitalisation prior to delivery, and mean arterial blood pressure at the first antenatal care visit.
bMean (SD), mean difference with 95% confidence intervals.
c.90th population percentile for gestational age.
d,10th population percentile for gestational age.
eIntensive neonatal care defined as admission to the neonatal unit for care more intensive than normal newborn care and lasting more than 24 h, excluding suspected
sepsis, observation, and feeding problems.
NA, not applicable.
doi:10.1371/journal.pmed.1001272.t003





(Percent) aORa (95% CI)
GDM, n=164
(Percent) aORa (95% CI)
Preeclampsia 35 (1.63) 10 (2.59) 1.40 (0.68–2.89) 1 (0.61) 0.50 (0.18–1.39)
Primary caesarean section 720 (33.46) 121 (31.35) 0.81 (0.63–1.05) 67 (40.85) 1.13 (0.94–1.37)
Induction of labour 58 (2.84) 14 (3.88) 1.28 (0.69–2.34) 12 (7.64) 1.51 (1.08–2.11)
Severe perineal traumab 52 (2.81) 10 (3.06) 1.11 (0.55–2.23) 4 (2.78) 1.0 (0.59–1.72)
Postpartum haemorrhage
(.500 ml)
93 (4.32) 16 (4.15) 1.0 (0.60–1.69) 6 (3.66) 0.90 (0.58–1.38)
aAdjusted for age, BMI at OGTT, height at OGTT, indoor partner’s smoking status, family history of diabetes, family history of hypertension, gestational age at OGTT,
baby’s sex, parity (not included in model for primary caesarean section), hospitalisation prior to delivery (not included in model for preeclampsia), mean arterial blood
pressure at the first antenatal care visit (not included in model for preeclampsia).
bFor women giving birth vaginally.
doi:10.1371/journal.pmed.1001272.t004
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section between the borderline group and the normal group (aOR
0.81, 95% CI 0.63–1.05), as was predicted from the data from the
HAPO cohort [4]. It is of note, however, that primary caesarean
section rates were much higher in the normal group (33.46%) in
our study compared to that reported in the HAPO cohort (16.0%)
[4]. Reasons for this high caesarean section rate are beyond the
scope of this study, although similar high levels have been noted in
other Asian metropolitan facilities [18], and there is evidence of a
preference for caesarean section by both women and medical staff
in some settings.
Introduction of universal screening for gestational diabetes in
Viet Nam using the IADPSG criterion would identify over 20% of
women as having GDM, compared to 6.1% if the ADA 2010
criterion were adopted.
A limitation of observational studies is the generalisability of
these findings to similar populations. Whilst there was a high rate
of participation and follow-up of eligible women, it is acknowl-
edged that many women seeking care in this institution were not
eligible. Women with high-risk pregnancies or known diabetes
(including gestational) were excluded, and thus the prevalence of
GDM in this study is likely to be an underestimate for the hospital,
yet likely more reflective of the local metropolitan population. The
study lacked blinding in outcome measurement as additional
information on GDM management was obtained. Given the
strong evidence to support identification and treatment of severe
hyperglycaemia in pregnancy [8], it was felt unethical to deny
treatment to women with more severe glucose intolerance. An
attempt was made to minimise this as a source of bias by having a
structured questionnaire for outcome measurement, and the
health providers completing patient records were unaware of the
study outcomes. The study is strengthened by the prospective
design, defined aims, high rate of follow-up for women and babies
in the cohort (97.5% of women who underwent OGTT screening),
and ability to adjust for several possible confounding variables.
The use of local birth weight for gestation percentile charts could
be criticised as not representing optimal growth. Until the release
of the proposed World Health Organization birth weight charts
for gestational age, it was felt the local charts were appropriate.
The mean birth weight for Vietnamese females born at 40 wk is
3,166 g and for males is 3,330 g, the 90th percentiles being
3,650 g and 3,760 g, respectively. These figures are significantly
lower than the mean Australian population birth weight standards
at 40 wk, 3,450 g for females and 3,600 g for males, and the 90th
percentiles 4,000 g and 4,170 g, respectively [19]. Babies born to
mothers with GDM with normal birth weight have been found to
have higher body fat percentage than those born to mothers with
normal glucose tolerance [20], and it may be that this is a better
measure of metabolic disturbance in the neonate than weight for
gestational age or weight greater than 4,000 g. We lacked the
resources to measure body fat composition, and so LGA has been
used as a proxy measure for increased neonatal growth.
The number of women who commenced on insulin, 11 (6.5% of
the GDM group), is lower than reported from other settings.
Whilst diagnostic criteria and thresholds for commencement of
insulin differ across settings, rates of reported insulin usage in
women with GDM range from 17% to 40% [3,21,22]. The lower
rates of insulin use in this study are likely related to the less
frequent monitoring, with 80% of women monitoring glucose
levels twice a week or less often. This may have contributed to the
relatively high rate of neonatal hypoglycaemia seen in the GDM
group (14.02%), although it is of note that of the 141 babies born
preterm to mothers in the normal group, only 15 developed
clinical neonatal hypoglycaemia.
Inadequate or less-intensive treatments for GDM in retrospec-
tive studies from India [23] and South Africa [24] have been found
to be associated with increased perinatal mortality compared to
treatment deemed adequate. Neither of these studies controlled for
confounding, and both studies included women with minimal
antenatal care diagnosed with GDM very late in gestation. We did
not demonstrate a difference in perinatal mortality in this study
between the women with and without GDM, although this study
was underpowered to demonstrate a difference in this outcome. In
this study all women had regular and frequent antenatal care from
an average of 12 wk gestation, and education and literacy rates
were relatively high, with over 90% of women having completed
at least primary school. Low education and infrequent antenatal
care are known to be associated with stillbirth in this population
[25], thus the findings from this study may not be generalisable to
the Vietnamese population as a whole.
Our study has confirmed that GDM occurs at much lower BMI
in Vietnamese women than in Caucasian women. The mean BMI
for women in the GDM group was 21.0 kg/m2 and in the
borderline group was 20.22 kg/m2. Using the World Health
Organization Asian reference categories [26], 15.5% of women
were classified as overweight (BMI 23–27.5 kg/m2) and 1.8% of
women obese (BMI.27.5 kg/m2). An Australian study examining
Table 5. Outcomes related to the 75-g oral glucose tolerance test results analysed as continuous variables.
Outcome Plasma Glucose Level Odds Ratio
a (95% CI)
Fasting 1 h 2 h
Primary caesarean section 1.08 (0.99–1.17) 1.03 (0.94–1.12) 1.04 (0.96–1.14)
Preeclampsia 1.04 (0.87–1.25) 1.01 (0.83–1.23) 1.04 (0.87–1.24)
LGA 1.20 (1.08–1.34) 1.20 (1.07–1.33) 1.16 (1.04–1.30)
SGA 0.93 (0.80–1.09) 0.81 (0.70–0.95) 0.84 (0.72–0.97)
Labour induction 1.18 (0.96–1.44) 1.31 (1.05–1.62) 1.29 (1.07–1.57)
Neonatal hypoglycaemia 1.46 (1.18–1.81) 2.29 (1.74–2.99) 2.07 (1.66–2.58)
Neonatal jaundice requiring phototherapy 1.16 (0.95–1.40) 1.22 (0.98–1.51) 1.14 (0.93–1.40)
Preterm birth (,37 wk) 1.27 (1.11–1.45) 1.22 (1.06–1.42) 1.20 (1.04–1.38)
Intensive neonatal care 0.98 (0.81–1.20) 1.30 (1.07–1.57) 1.05 (0.87–1.26)
aOdds ratios were for an increase in the glucose level of one SD (0.42 mmol/l [7.6 mg/dl] for the fasting plasma glucose level, 1.6 mmol/l [28.9 mg/dl] for the 1-hr
plasma glucose level, and 1.4 mmol/l [24.8 mg/dl] for the 2-hr plasma glucose level).
doi:10.1371/journal.pmed.1001272.t005
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differences in insulin resistance between ethnic groups in women
with GDM found a much lower BMI in Asian women than in
other ethnic groups for the same degree of insulin resistance [27].
It has also been shown that as BMI increases in Asian women,
there is a significantly greater increase in insulin resistance than in
Caucasian women [28].
The low rates of overweight and obesity in both the GDM and
normal groups in our study resulted in only a 4.7% population
attributable fraction of overweight and obesity for GDM in
Vietnamese women. In North America it has been estimated that
the population attributable fraction of overweight and obesity for
GDM is 46.2% [29]. This raises the question of why the rates of
GDM are so high in this population. Whilst GDM is likely
multifactorial in origin, it has been proposed that genetic
predisposition [30] and/or foetal programming [31] are likely to
be of key importance.
In the HAPO cohort study the mean BMI was 27.765.1 kg/
m2, with means from study centres ranging from 24.4 to 29.9 kg/
m2 [4]. We feel our study is important as it demonstrates that in
women with lower BMI, the frequency of adverse outcomes
secondary to hyperglycaemia is lower than in populations where
the mean BMI is in the overweight range.
In Western populations there appears to be a synergistic effect
of GDM and obesity. In a review of 3,789 women with GDM
from the United States, the risk of composite adverse neonatal
outcome (birth weight .4,000 g, birth trauma, shoulder dystocia,
hypoglycaemia, or jaundice) increased from 20.4% for normal
weight (BMI 18.5–24.9 kg/m2) to 35.9% in women with morbid
obesity (p,0.001) [32]. Given the low rate of overweight and
obesity, our study was underpowered to replicate these findings.
In this study the rate of preeclampsia was low, 1.70%, with no
difference between the GDM groups. Hyperglycaemia in preg-
nancy has been associated with the development of preeclampsia
[9], with the ACHOIS trial demonstrating that treatment of mild
hyperglycaemia can decrease preeclampsia (relative risk 0.70, 95%
CI 0.51–0.95) [3]. Whilst this association was also demonstrated in
the HAPO cohort [4], post hoc analysis demonstrated the
relationship between preeclampsia and BMI to be stronger than
that with hyperglycaemia [33].
Despite the fact that Asian expatriate women have higher rates
of GDM than Caucasian women [34,35], they appear to have less
preeclampsia. In a retrospective review of 902,000 women giving
birth in New York City from 1995 to 2003, East Asian women had
the lowest rates of preeclampsia (1.4% compared to 3.2% overall)
[36]. The low prevalence of preeclampsia and the low BMI in our
study may have resulted in type 1 error in failing to demonstrate
an association with GDM.
The proposed IADPSG guidelines have generated much
controversy and discussion amongst clinicians globally working
in the area of GDM. Our study demonstrates a 300% increase in
GDM prevalence if the IADPSG criterion is adopted in Viet Nam.
Retrospective studies from several countries also demonstrate that
use of the IADPSG criterion will significantly increase workload.
In Australia, prevalence of GDM would increase from 7.7% to
9.4% [37], in Japan, from 2.4% to 6.6% [38], and in the United
Arab Emirates, from 12.9% to 37.7% [39].
Conclusion
The proposed IADPSG criterion for GDM would identify more
women as having GDM who are at risk of having a preterm birth
or a baby requiring treatment for neonatal hypoglycaemia. Before
recommending that this screening method be adopted in Viet
Nam, these findings need to be balanced against the ability of a
low-resource hospital to manage such a large number of women
with GDM. Without evidence of the benefit of treatment for the
women in the borderline group, it is difficult to recommend
adoption of the IADPSG guidelines in Viet Nam at present. The
current low prevalence of overweight and obesity in pregnant
women may be offering some protection against other adverse
outcomes associated with milder degrees of GDM. The long-term
significance of a diagnosis of GDM using the IADPSG definition
in predicting future risk of type 2 diabetes mellitus is not known.
Future research needs to be directed at examining the short- and
long-term benefits as well as potential harms and opportunity costs
of screening and treating GDM in low-income settings before
‘‘universal’’ screening in pregnancy can be recommended.
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Editors’ Summary
Background. Gestational diabetes mellitus (GDM) is diabe-
tes that is first diagnosed during pregnancy. Like other types
of diabetes, it is characterized by high levels of sugar
(glucose) in the blood. Blood-sugar levels are usually
controlled by insulin, which is made by the pancreas.
Hormonal changes during pregnancy and the baby’s growth
demands increase a pregnant woman’s insulin needs, and if
her pancreas cannot make enough insulin, GDM develops,
usually in mid-pregnancy. Risk factors for GDM include a
high body mass index (a measure of body fat), excessive
weight gain or lack of physical activity during pregnancy,
and glucose intolerance (an indicator of diabetes that is
measured using the ‘‘oral glucose tolerance test’’). GDM
increases the risk of premature delivery, induced delivery,
and having a large-for-gestational-age baby (gestation is the
time during which the baby develops within the mother). It
also increases the baby’s risk of having low blood sugar
(neonatal hypoglycemia). GDM, which can often be con-
trolled by exercise and diet, usually disappears after
pregnancy but increases the risk of diabetes developing
later in both mother and baby.
Why Was This Study Done? The prevalence (occurrence)
of diabetes is increasing rapidly, particularly in low/middle-
income countries as they become more affluent. Because
GDM increases the subsequent risk of diabetes, some experts
believe that screening for GDM should be included in
prenatal care as part of diabetes preventative strategies.
However, most of the evidence supporting GDM screening
comes from high-income countries, so in this prospective
cohort study (a study that analyses associations between the
baseline characteristics of a group of patients and out-
comes), the researchers investigate the prevalence of GDM
(diagnosed using the oral glucose tolerance test) and the
consequences of GDM among women attending an urban
hospital in Viet Nam, a low/middle-income country. An oral
glucose tolerance test measures a patient’s blood-sugar level
after an overnight fast, and one and two hours after
consuming a sugary drink. The International Association of
the Diabetes and Pregnancy Study Groups (IADPSG) and the
American Diabetes Association (ADA) guidelines state,
respectively, that one and two of these blood-sugar
measurements must be abnormally high for a diagnosis of
GDM. In this study, the researchers use both guidelines to
diagnose GDM.
What Did the Researchers Do and Find? Nearly 3,000
women who attended the hospital for routine prenatal care
had a glucose tolerance test at around 28 weeks’ gestation
and were followed until discharge after delivery. Women
who had GDM diagnosed by the ADA criterion were referred
for dietary advice and glucose monitoring. Those diagnosed
by the IADPSG criterion only were described as having
‘‘borderline’’ GDM and received standard prenatal care. GDM
was diagnosed in 6.1% and 20.3% of the women using the
ADA and IADPSG criteria, respectively. After allowing for
other factors that might have affected outcomes, compared
to women without GDM, women with GDM or borderline
GDM were more likely to deliver prematurely, and their
babies were more likely to have neonatal hypoglycemia.
Also, women with GDM (but not borderline GDM) were more
likely to have their labor induced than women without GDM.
What Do These Findings Mean? These findings show
that the criterion used to diagnose GDM markedly affected
the prevalence of GDM among pregnant women attending
this Vietnamese hospital—the use of the IADPSG criterion
more than tripled the prevalence of GDM and meant that a
fifth of the study participants were diagnosed as having
GDM. Importantly, the findings also show that GDM
diagnosed using the IADPSG criterion was associated with
an increased risk of preterm delivery and neonatal hypogly-
cemia. Although these findings may not be generalizable to
other settings within Viet Nam or to other countries, they
highlight the need to demonstrate that sufficient resources
are available to cope with an increased GDM burden before
recommending widespread screening using the IADPSG
criterion. Moreover, because the long-term significance of
GDM diagnosed using the IADPSG criterion is not known, all
the potential benefits and harms and the costs of screening
and treating GDM in low-income settings need to be further
investigated before any recommendation for ‘‘universal’’
GDM screening is made.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001272.
N The US National Institute of Diabetes and Digestive and
Kidney Diseases provides information for patients on
diabetes and on gestational diabetes (in English and
Spanish)
N The UK National Health Service Choices website also
provides information for patients about diabetes and
about gestational diabetes, including links to other useful
resources
N The American Diabetes Association also provides detailed
information for patients and professionals about all
aspects of diabetes, including gestational diabetes (in
English and Spanish)
N The International Association of the Diabetes and Preg-
nancy Study Groups (IADPSG) 2010 recommendations on
the diagnosis and classification of gestational diabetes are
available
N The charity Diabetes UK provides detailed information for
patients and carers, including information on gestational
diabetes; its blog includes a personal story about
gestational diabetes, and its website includes a selection
of other stories from people with diabetes; the charity
Healthtalkonline also has an interview describing a
personal experience of gestational diabetes
N MedlinePlus provides links to additional resources on
diabetes and on gestational diabetes (in English and
Spanish)
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